ALKEM LABORATORIES share price has plunged 3% and is presently trading at Rs 5,180.6.
Meanwhile, the BSE HEALTHCARE index is at 38,209.1 (down 0.6%).
Among the top losers in the BSE HEALTHCARE index today are HIKAL CHEMIC (down 2.5%) and LAURUS LABS (down 2.3%).
Pfizer (up 4.4%) and KIMS (up 2.2%) are among the top gainers today.
Over the last one year, ALKEM LABORATORIES has moved up from Rs 3,483.9 to Rs 5,180.6, registering a gain of Rs 1,696.7 (up 48.7%).
On the other hand, the BSE HEALTHCARE index has moved up from 25,922.2 to 38,209.1, registering a gain of 47.4% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were Glenmark Pharma (up 101.1%), Lupin (up 99.8%) and Cadila Healthcare (up 98.6%).
Dear Reader: If You Invest in Midcap Stocks, this is for You
The BSE Sensex is at 79,623.5 (down 0.9%).
The top losers among the BSE Sensex today are M&M (down 6.6%) and HCl Tech. (down 2.6%). The most traded stocks in the BSE Sensex are Tata Steel and ITC.
In the meantime, NSE Nifty is at 24,217.1 (down 0.9%). M&M and HCl Tech. are among the top losers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 65,344.2 to 79,623.5, registering a gain of 14,279.3 points (up 21.9%).
ALKEM LABORATORIES net profit grew 349.9% YoY to Rs 3,045 million for the quarter ended March 2024, compared to a profit of Rs 677 million a year ago. Net sales rose 1.1% to Rs 29,358 million during the period as against Rs 29,026 million in January-March 2023.
For the year ended March 2023, ALKEM LABORATORIES reported 40.1% decrease in net profit to Rs 10,068 million compared to net profit of Rs 16,803 million during FY22. Revenue of the company grew 9.1% to Rs 115,993 million during FY23.
The current Price to earnings ratio of ALKEM LABORATORIES, based on rolling 12 month earnings, stands at 34.2.
Equitymaster requests your view! Post a comment on "ALKEM LABORATORIES Plunges 3%; BSE HEALTHCARE Index Down 0.6%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!